AVTR Avantor, Inc.
Healthcare$8.12+3.18%ClosedMarket Cap: $5.54B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.99
P/S
0.85
EV/EBITDA
40.44
DCF Value
$30.44
FCF Yield
7.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
32.1%
Operating Margin
-4.3%
Net Margin
-8.4%
ROE
-9.6%
ROA
-4.7%
ROIC
-2.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.58B | 31.7% | $115.0M | $43.3M | $— | — |
| Q4 null | $1.66B | 31.5% | $126.4M | $52.4M | $— | — |
| FY null | $6.55B | 32.7% | $-246.2M | $-530.2M | $— | — |
| Q3 null | $1.62B | 32.4% | $-648.8M | $-711.8M | $— | — |
| Q2 null | $1.68B | 32.9% | $128.8M | $64.7M | $— | — |
| Q1 null | $1.58B | 33.8% | $147.4M | $64.5M | $— | — |
| Q4 null | $1.69B | 33.4% | $638.1M | $500.4M | $— | — |
| FY null | $6.78B | 33.6% | $1.08B | $711.5M | $— | — |
| Q3 null | $1.71B | 32.9% | $124.6M | $57.8M | $— | — |
| Q2 null | $1.70B | 34.1% | $175.8M | $92.9M | $— | — |
| Q1 null | $1.68B | 34.0% | $146.3M | $60.4M | $— | — |
| Q4 2023 | $1.72B | 33.1% | $183.3M | $98.5M | $0.15 | — |